Jefferies raises Rapport Therapeutics target price to $64 from $55
RAPP•Jefferies raised its target price for Rapport Therapeutics to $64 from $55.
Related News
XPLR Infrastructure LP: Jefferies cuts target price to $14 from $16
XIFR•
Jefferies cuts GM target price to $95 from $99
GM•
CIBC initiates coverage of Equinix with outperformer rating and $1,200 price target
EQIX•
Eli Lilly: Leerink Partners raises target price to $1,316 from $1,309
LLY•
Oppenheimer cuts Braze to perform from outperform
BRZE•